Mesh Device Not Risk-Free, But Is FDA Approved, Says Defense in Trial
Javascript is required to watch this video
If you have enabled JavaScript and still cannot play the video, please contact support.
Robert Adams tells jurors that Boston Scientific’s Solyx pelvic mesh device is not risk-free, it is considered safe and effective by the U.S. Food and Drug Administration. Adams represents Boston Scientific in Eve Sherrer’s suit against the company for chronic pain she says was caused by the Solyx.
View Similar Clips
- More from the Proceeding
- Sherrer v. Boston Scientific, et al.
- More from Industry
- Health care
- More from Practice Area
- Products Liability
- More from Judge
- Robert Scheiber
- More from Court
- Jackson County Courthouse
- Jurisdiction
- 16th Judicial Circuit of Missouri